73 results
DEFM14A
HARP
Harpoon Therapeutics Inc
8 Feb 24
Proxy related to merger
7:00am
with the Merger. In connection with this engagement, the Board requested that Centerview evaluate the fairness, from a financial point of view … to receive an offer to acquire the company. The representatives of Goodwin also reviewed the terms of the proposed engagement of Centerview as Harpoon’s
PREM14A
HARP
Harpoon Therapeutics Inc
29 Jan 24
Preliminary proxy related to merger
4:52pm
with this engagement, the Board requested that Centerview evaluate the fairness, from a financial point of view, to the holders of Company Shares (other … an offer to acquire the company. The representatives of Goodwin also reviewed the terms of the proposed engagement of Centerview as Harpoon’s financial
DEFA14A
HARP
Harpoon Therapeutics Inc
8 Jan 24
Additional proxy soliciting materials
8:04am
Partners LLC, an accurate and complete copy of whose engagement letter has been made available to Parent, no agent, broker, investment banker, finder … or independent contractor with respect to the Company in relation to the engagement of any individual is pending or, to the knowledge of the Company
8-K
EX-2.1
HARP
Harpoon Therapeutics Inc
8 Jan 24
Entry into a Material Definitive Agreement
8:01am
, an accurate and complete copy of whose engagement letter has been made available to Parent, no agent, broker, investment banker, finder, Person or firm … contractor with respect to the Company in relation to the engagement of any individual is pending or, to the knowledge of the Company, threatened, nor
8-K
EX-99.1
z14c5yfila70f6 d9yxt
23 Oct 23
Other Events
8:00am
PRE 14A
l8lbmbg1 ho
14 Apr 23
Preliminary proxy
4:54pm
8-K
EX-99.2
e3a ehl1cnx
12 Dec 22
Harpoon Therapeutics Presents Updated Interim Results at ASH 2022 for Novel T Cell Engager HPN217 in Relapsed/Refractory Multiple Myeloma
4:03pm
8-K
EX-99.1
d8emx 0cmr
10 Aug 22
Harpoon Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:14pm
8-K
xt1uv8u4d50j3 g43
3 Jun 22
Regulation FD Disclosure
5:05pm
8-K
EX-99.1
350nkvc 46gby
10 Mar 22
Harpoon Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:16pm
8-K
EX-99.1
l2gweb1q7lpx
11 Jan 22
Other Events
6:16am